Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry
ISSN 1990-7508 · eISSN 1990-7516 · Pleiades Publishing · 4 issues per year
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.4 (journal website); subscription journal; median 71 days to acceptance (77 articles, last 24 months); 45 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry is published by Pleiades Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Biochemical effects in animals, Computational Drug Discovery Methods and Advanced Proteomics Techniques and Applications, together about 19.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY
Editor-in-chief Andrey A. ZamyatninPublisher website
Editorial board by country: none in mainland China; most named Russia 9 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Biochemical effects in animalsMedicine7.7%
- Computational Drug Discovery MethodsComputer Science6.6%
- Advanced Proteomics Techniques and ApplicationsChemistry5.5%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology5.3%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.7%
- Free Radicals and AntioxidantsChemistry4.7%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics4.6%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.4Publisher website ·
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.16LetPub ·
- SNIP 2026-06
- 0.09LetPub ·
- h-index
- 21OpenAlex ·
- i10-index
- 87OpenAlex ·
- 2-year mean citedness
- 0.48OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0.93%LetPub ·
Volume
- Articles per year
- 39LetPub ·
- Downloads per year (publisher) 2025
- 16,600Publisher website ·
Articles by year OpenAlex count · 875 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 0 | 0 |
| 2025 | 45 | 2 | 17 |
| 2024 | 48 | 0 | 37 |
| 2023 | 22 | 0 | 28 |
| 2022 | 37 | 5 | 58 |
| 2021 | 37 | 5 | 178 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
71 daysMedian, submission to acceptance · P25–P75 30 days – 133 days
- Acceptance to online
- median 123 days (77 articles)
- Submission to online
- median 194 days
- Sample
- 77 articles with submission and acceptance dates (88 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted1
- editorialDouble-blind peer review This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout p…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright transfer agreement
A completed copyright transfer agreement (in Russian or English) should be submitted together with the manuscript through the Editorial Publishing System or via e-mail, if a journal is not registered in this system. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Authors will have the option to choose how their article is published. Subscription publishing model - Published articles are made available to institutions and individuals who subscribe to Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry or who pay to read specific articles. If you would be interested in publishing open access in this journal please contact the Open Research Suppo…
Source ↗Publisher website ·- Peer review Double-blind peer review
This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as …
Source ↗Publisher website ·- Plagiarism Important note: the journal may use software to screen for plagiarism.
Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several author…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes“. The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pleiades Publishing
- Frequency
- 4 issues per year
- ISSN
- 1990-7508
- Electronic ISSN
- 1990-7516
- Latest issue on the website
- Volume 20, Issue 2 (June 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Biochemistry Moscow-Supplement Series B-Biomedical Chemistry
What CAS zone is Biochemistry Moscow-Supplement Series B-Biomedical Chemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biochemistry Moscow-Supplement Series B-Biomedical Chemistry is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biochemistry Moscow-Supplement Series B-Biomedical Chemistry?
The journal's website gives an impact factor of 0.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 0.6, h-index 21.
How long does peer review take at Biochemistry Moscow-Supplement Series B-Biomedical Chemistry?
Based on the dates recorded on 77 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 30–133 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Biochemistry Moscow-Supplement Series B-Biomedical Chemistry?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Biochemistry Moscow-Supplement Series B-Biomedical Chemistry based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Biochemistry Moscow-Supplement Series B-Biomedical Chemistry?
According to LetPub and DOAJ records, Biochemistry Moscow-Supplement Series B-Biomedical Chemistry is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Biochemistry Moscow-Supplement Series B-Biomedical Chemistry open access, and what is the APC?
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .